JACQUES JM
VAN DONGEN
Investigador
University of Padua
Padua, ItaliaPublicaciones en colaboración con investigadores/as de University of Padua (13)
2016
-
Increased PI3K/Akt activity and deregulated humoral immune response in human PTEN deficiency
Journal of Allergy and Clinical Immunology, Vol. 138, Núm. 6, pp. 1744-1747.e5
2013
-
The MLL recombinome of acute leukemias in 2013
Leukemia, Vol. 27, Núm. 11, pp. 2165-2176
2011
-
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: Results of the AIEOP-BFM-ALL 2000 study
Blood, Vol. 118, Núm. 8, pp. 2077-2084
-
Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: First evidence for genetic predisposition
Journal of Clinical Oncology, Vol. 29, Núm. 12, pp. 1643-1649
2010
2009
-
New insights to the MLL recombinome of acute leukemias
Leukemia, Vol. 23, Núm. 8, pp. 1490-1499
-
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
Leukemia, Vol. 23, Núm. 6, pp. 1073-1079
2008
2007
-
Acute lymphoblastic leukemia with t(4;11) in children 1 year and older: The 'big sister' of the infant disease?
Leukemia, Vol. 21, Núm. 4, pp. 642-646
-
Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement
Leukemia, Vol. 21, Núm. 4, pp. 633-641
-
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting
Leukemia, Vol. 21, Núm. 4, pp. 706-713
2005
-
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection
Clinical Cancer Research, Vol. 11, Núm. 21, pp. 7720-7727
2004
-
High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias
Leukemia, Vol. 18, Núm. 1, pp. 84-91